Aegon's recommendation has been upgraded by UBS from 'hold' to 'buy', with a slightly lower price target of €6.55 compared to €6.65. This new target indicates a potential 12% increase in the stock of the Dutch insurer.
UBS notes that Aegon offers a yield that is 9% higher than the sector average, making it an attractive investment opportunity. Furthermore, UBS expects Aegon to announce a €100 million share buyback program alongside its third-quarter 2024 results, which is seen as a positive move to enhance shareholder value and reflects confidence in Aegon's future financial performance.